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Introduction 
In [l-3], difference of glycolipid compositions 
has been demonstrated between the island-forming 
cell type (maintaining cell adhesiveness) and the free 
cell type (lacking in cell adhesiveness) of rat ascites 
hepatoma cells. In general, the former was charac- 
terized by GM3 as its sole ganglioside, while the latter 
was by the presence of asialo-GMa, asialo-GM ,, fuco- 
lipid and gangliosides giving the same RF value as 
GMr, and GDr, on thin-layer plate. However, the 
GM, synthesized in vitro from asialo-GM1 and CMP- 
NeuAc by the sialyltransferase in AH 7974F (free 
cell type) was found to be GMrb [4]. It is interesting 
to know whether GMrb is present in the free cells or 
not. The present paper is concerned with the detailed 
analysis of ganglioside structures in AH 7974F cells. 
2. Materials and methods 
The cells, AH 7974F, were transplanted to rats of 
Moriyama inbred strain, (-150 g). After feeding 
animals for 4 days, the ascitic fluid was taken out and 
centrifuged at 600 rev./min for 10 min to sediment 
the tumor cells. The tumor cells were washed several 
times with 0.9% NaCl solution to remove red blood 
cells, and finally lyophilized [3] Total lipids were 
Abbreviations: C-M-W, chloroform-methanol-water; 
NeuAc, N-acetylneuraminic acid; asialo-GM,, GalNAc- 
Gal-Glc-ceramide; asialo-GM,, Gal-GalNAc- 
Gal-Glc-ceramide; GM,,, Gal-GalNAc-(NeuAc)-Gal- 
Glc-ceramide; paragloboside, Gal-GlcNAc-Gal-Glc- 
ceramide; MS, mass spectrometry; TLC, thin-layer chro- 
matography; GLC, gas-liquid chromatography 
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extracted from the lyophilized cells (37 g) with 20 vol. 
C-M (2: 1, v/v) and the residue was extracted again 
with the same volumes of C-M (1: 1, v/v). The com- 
bined extracts were evaporated to dryness at 40°C 
under vacuum. Acidic lipids were separated from 
neutral lipids on a DEAE-Sephadex A-25 column 
[5]. The acidic lipid fraction was subjected to per- 
acylation, which was followed by Florisil column 
chromatography as in [6] . By this procedure, 22 mg 
ganglioside was obtained from the starting materials. 
Rechromatography on DEAE-Sephadex A-25 
column (1 .l X 35 cm) of the total ganglioside frac- 
tion was carried out with linearly increasing ammonium 
acetate (Am AC) in methanol (from 0.03-0.3 M AmAc 
solution). The distribution of gangliosides in effluent 
fractions was detected by TLC (fig.1) [7]. All of the 
gangliosides eluted with 0.04-0.07 M AmAc (mono- 
sialo-ganglioside), which, however, could not be 
separated from each other on the column, were then 
subjected to Iatrobeads (6RS-8060, Iatron Co. Ltd., 
Tokyo) column chromatography (0.7 X 120 cm) 
using a linear gradient of C-M-W (from 83: 16:0.5 to 
20:80:5, v/v/v, 300 ml each) for the isolation of 
individual ganglioside [7]. As shown in fig.2, 5 gan- 
gliosides were purified by repeating the column chro- 
matography at least 2 times. These gangliosides were 
designated as A, B, C, D and E from the top to the 
bottom of the thin-layer chromatogram, the 
mobilities of which corresponding to those of GMa, 
GM2, sialylparagloboside, GMr, and GDr,, respec- 
tively. The final yields of these purified gangliosides, 
A, B, C, D and E from 37 g dried cells were -0.15 mg, 
0.1 mg, 1.5 mg, 3.0 mg and 0.9 mg, respectively. 
The sugar and fatty acid compositions were 
analyzed by GLC as in [3]. The long-chain bases were 
also analyzed by GLC as in [8]. 
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Fig.1. Elution pattern of AH 7974F gangliosides from DEAE-Sephadex A-25 column. Total ganglioside fraction (20 mg) was 
applied to a DEAE-- Sephadex column with a linear gradient of a AmAc in methanol. Fractions (4 ml) were collected and each 
fraction was analyzed by TLC with a solvent system of C-M-ammonia 2.5 N (60:40:9, v/v/v). The spots were visualized by 
resorcinoi reagent. 
Fig.2. Thin-layer chromatogram of the ganglioside from AH 7974F. Each ganglioside was isolated by repeating (at least 
2 times) Iatrobeads column chromatography as described in the text. TLC was performed with a solvent system as described 
in fig. 1. Std., the mixture of standard gangliosides from bovine brain. 
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The isolated gangliosides, C and D were per- 
methylated as in [9]. Partially methylated alditol 
acetates from the permethylated glycolipids were 
obtained as in [lo]. Partially methylated neutral and 
N-acetamidoalditol acetates were analyzed on a 
column (1.5 m long) of 5% ECNSS-M on Chromosorb 
WAW 60-80 mesh, at 150°C by GLC [lo-121. The 
alditol acetates were also identified on a combined 
GC-MS system by reference to the data in [ 10,13- 151 
GC-MS was performed as in [ 161. 
Hydrolysis of the gangliosides C and D with neur- 
aminidase from Clostridium perfringens (Sigma, 
type IV) was as in [ 171. After incubation for 72 h at 
37”C, the reaction mixture was dialyzed against 
distilled water (10 ml) for 3 days at 4°C. Non- 
dialyzable materials were analyzed by TLC. The 
dialyzable materials were subjected to TLC for the 
determination of species of sialic acid as in [ 181. 
3. Results 
3 .l . Chemical structure of ganglioside C 
Ganglioside C migrated to a position between GM* 
and GM,, on a thin-layer plate (flg.2). As shown in 
table 1, this ganglioside was found to contain glucose, 
galactose, N-acetylglucosamine and sialic acid in the 
molar ratios of 1:2: 1: 1. Neuraminidase from Cl. per- 
fringens converted it into paragloboside, which 
migrated between asialo-GM, and asialo-GM, (fig.3) 
with the liberation of N-acetylneuraminic acid which 
was identified in the dialysate of the reaction mixture 
by TLC. Partially methylated alditol acetates from 
ganglioside C were identical to those from sialyl- 
paragloboside from human erythrocytes (table 2). 
These studies indicated that the chemical structure of 
ganglioside C was as follows: NeuAc (2-3) Gal (l-4) 
GlcNAc (l-3) Gal (l-4) Glc-ceramide (sialylpara- 
globoside). As shown in table 3, C18:0 and CX4:r are 
the dominant fatty acid in the ganglioside C. C-18 
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Fig.3. Thin-layer chromatogram of hydrolysis products of 
ganglioside C (lane 1) and D (lane 2) with neuraminidase 
from Cl. perfringens. The spots were visualized by a-naphthol/ 
H,SO, reagent. Lane 3, asialoCM,; Lane 4, asialo-GM,. TLC 
was performed with a solvent system of C-M-W (60:35:8, 
v/v/v). 
Dihydrosphingosine was the major (52%) long-chain 
base of this ganglioside detected. 
3.2. Chemical structure of ganglioside Ll 
Ganglioside D moved identically with authentic 
GM,, obtained from bovine brain (fig.2). GLC 
analysis of its sugar composition showed that 
ganglioside D contained glucose, galactose, N-acetyl- 
galactosamine and sialic acid in the molar ratios of 
1:2: 1: 1 (table 1). Neuraminidase from Cl. perfringens 
Table 1 
Sugar compositions of isolated gangliosides 
Ganglioside Glucose Galactose Galactosamine Glucosamine Sialic acid 
C 1.0 1.7 _ 0.7 0.8 
D 1.0 2.2 1.0 _ 1.1 
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Table 2 
Partially methylated alditol acetates from isolated gangliosides 
Alditol acetates Glc Gal Gal 
Position of CH, 2,336 2,3,4,6 2,3,6 
Ganglioside 
C + _ 
D + _ + 
converted the lipid into asialo-GM1 (fig.3). This 
finding showed that ganglioside D was different from 
GM,,, since GM1, is resistant to the enzyme under 
usual incubation conditions [ 191 . The sialic acid 
released by the enzyme was found to be N-acetyl- 
neuraminic acid. Analysis of partially methylated 
alditol acetates indicated that the chemical structure 
of ganglioside D was as follows: NeuAc (2-3) Gal 
(l-3) GalNAc (l -4)Gal(l-4) Glc-ceramide (GM 1b). 
Compositions of the fatty acid and long-chain base 
were similar to those of ganglioside C (table 3). 
4. Discussion 
We have isolated 5 monosialo-ganglioside (A, B, C, 
Table 3 
Fatty acid and long-chain base compositions of 
isolated gangliosides 
Ganglioside 
NAF C 
16:0 3.2 
16:l 5.1 
18:0 21.9 
18:l 4.9 
20:o 5.5 
22:o 10.9 
24:0 14.1 
24:l 30.3 
LCB 
d18:O 52.1 
d18:l 25.3 
d20:O 14.2 
d20: 1 8.0 
NFA, normal fatty acid; LCB, long-chain base 
D 
6.9 
1.3 
12.4 
0.3 
16.0 
15.8 
19.7 
26.4 
57.6 
21.6 
8.9 
6.0 
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Gal Gal GalNAc GlcNAc 
2,4,6 2,6 4,6 3,6 
t _ + 
+ + _ 
D, E) from AH 7974F cell line. Two major gangliosides 
were characterized as sialylparagloboside and GM Ib. 
In both gangliosides, sialic acid was found to link to 
non-reducing terminal galactose of paragloboside and 
asialo-GM,, respectively. This finding was also con- 
firmed by resistance to galactose oxidase and NaB3H4 
labelling technique as in [20]. 
In [3] we reported the presence of asialo-ganglio- 
sides in the free cell type of hepatomas, and GM, 
synthesized from asialo-GM, and CMP-NeuAc by 
sialyltransferase in AH 7974F cells was shown to be 
GM,b but not GM1, [a], suggesting the natural 
presence of GMIb in the cells. In the present paper, it 
is described that the presence of GM,b was con- 
firmed by GLC, GC-MS and enzymatic hydrolysis 
studies. This is the first report on the natural occur- 
rence of GM,b in the mammalian CdS. 
The presence of sialyltransferase catalyzing the 
transfer of sialic acid from CMP-NeuAc to asialo-GM1 
to form GM,b has been reported in rat brain [21]. We 
have also detected the enzyme activity in rat brain 
and liver (Y.H., T.T., unpublished results). Therefore, 
the enzyme is not tumor associated. From these 
observations, it seemed possible that GM,b would be 
found in the cells containing asialo-GM 1. Characteriza- 
tion of the enzyme concerning the biosynthesis of 
GM,b is now in progress in our laboratory. 
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